Number of the records: 1

gemtuzumab

SYS		d000079982
LBL		00000nz--a2200181n--4500
005		20250606222908.8
008		200101\|\|\|anznnbabn-----------\|-a\|a------
040		$b slo $a BA006 $d BA006
065		$a D09.408.051.247.500
065		$a D12.776.124.486.485.114.224.060.790
065		$a D12.776.124.790.651.114.224.060.790
065		$a D12.776.377.715.548.114.224.200.790
066		$a 01 $c 03
150		$a gemtuzumab $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x TO $x TU $x UL $x UR $2 slo
450		$w v $a Gemtuzumab Ozogamicin $2 eng
450		$w v $a Gemtuzumab-Ozogamicin $2 eng
450		$w v $a gemtuzumab ozogamicín $2 slo
450		$w v $a Mylotarg $2 slo
450		$w v $a CMA 676 $2 slo
550		$7 sllk_us_auth*d000922 $Y Immunotoxins $w P $a imunotoxíny
550		$7 sllk_us_auth*d000074322 $Y Antineoplastic Agents, Immunological $w P $a antineoplastiká imunologické
665		$a 2020 (2000) $2 eng
680	9-	$i Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA. $2 eng
750	-2	$a Gemtuzumab $2 eng
980		$x M

Number of the records: 1